Novocure (NVCR) Tops Q3 EPS by 4c

Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $50.1 million versus the consensus estimate of $43.55 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lands' End (LE) Tops Q1 EPS by 8c ; Offers Guidance
• Vera Bradley (VRA) Misses Q1 EPS by 26c ; Offers Guidance